3-Methylbenzonitrile | CAS:620-22-4

We serve 3-Methylbenzonitrile CAS:620-22-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Methylbenzonitrile

CAS No: 620-22-4
Product Name: 3-Methylbenzonitrile
Other Name:
3-Methylbenzonitrile
1-Cyano-3-methylbenzene
3-Methylbenzolcarbonitril
M-Tolunitrile
1-Methyl-3-cyanobenzene
3-Cyanotoluene
m-Methylbenzonitrile
m-Cyanotoluene
 
Density: 1.0±0.1 g/cm3
Boiling Point: 213.8±9.0 °C at 760 mmHg
Melting Point: −23 °C(lit.)
Molecular Formula: C8H7N
Molecular Weight: 117.148
Flash Point: 86.7±0.0 °C
Exact Mass: 117.057846
PSA: 23.79000
LogP: 2.12
Vapour Pressure: 0.2±0.4 mmHg at 25°C
Index of Refraction: 1.531
Water Solubility: <0.1 g/100 mL at 25 ºC
 
Specification
Appearance: Colorless transparent liquid or crystal
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, pesticide intermediates, dye intermediates.
Organic synthesis intermediates, mainly used in the synthesis of methyl benzoic acid.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Methylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-Cyanotoluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Cyanotoluene Use and application,m-Methylbenzonitrile technical grade,usp/ep/jp grade.


Related News: Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.2-Bromo-6-chloro-4-methylpyridine manufacturer Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-one supplier Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.4-Fluorobenzeneboronic acid vendor Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.